Open access · CC-BY
via OpenAlex
Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation
David Hernández-Silva, Joaquín Cantón-Sandoval, Francisco Juan Martínez-Navarro, Horacio Pérez‐Sánchez, Sofía de Oliveira, Víctoriano Mulero, Francisca Alcaraz‐Pérez, María Luisa Cayuela
International Journal of Molecular Sciences · 2022 · ▲ 23 citations
Abstract
Telomere(definition) shortening is the main molecular mechanism of aging, but not the only one. The adaptive immune system also ages, and older organisms tend to develop a chronic pro-inflammatory status with low-grade inflammation characterized by chronic activation of the innate immune system, called inflammaging(definition). One of the main stimuli that fuels inflammaging is a high nutrient intake, triggering a metabolic inflammation process called metainflammation. In this study, we report the anti-inflammatory activity of several senolytic drugs in the context of chronic inflammation, by using two different zebrafish models: (i) a chronic skin inflammation model with a hypomorphic mutation in spint1a, the gene encoding the serine protease inhibitor, kunitz-type, 1a (also known as hai1a) and (ii) a non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) model with inflammation induced by a high-fat diet. Our results show that, although these models do not manifest premature aging, the senolytic drugs dasatinib, navitoclax, and venetoclax have an anti-inflammatory effect that results in the amelioration of chronic inflammation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms231810468
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Hernández-Silva, D., Cantón-Sandoval, J., Martínez-Navarro, F.J., Pérez‐Sánchez, H., Oliveira, S.D., Mulero, V., Alcaraz‐Pérez, F., & Cayuela, M.L. (2022). Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms231810468
Vancouver
Hernández-Silva D, Cantón-Sandoval J, Martínez-Navarro FJ, Pérez‐Sánchez H, Oliveira SD, Mulero V, et al. Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms231810468.
BibTeX
@article{david2022Senesc,
title = {Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation},
author = {David Hernández-Silva and Joaquín Cantón-Sandoval and Francisco Juan Martínez-Navarro and Horacio Pérez‐Sánchez and Sofía de Oliveira and Víctoriano Mulero and Francisca Alcaraz‐Pérez and María Luisa Cayuela},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms231810468},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational research 2025
Open access · CC-BY
Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn's disease: A pilot study
Frontiers in Cardiovascular Medicine 2018
Open access · CC-BY
Source of Chronic Inflammation in Aging
Elsevier eBooks 2025
Citation only
Inflammation: chronic inflammation in aging
Nutrients 2025
Open access · CC-BY
Employing Nutrition to Delay Aging: A Plant-Based Telomere-Friendly Dietary Revolution
Nutrients 2025
Open access · OA
Employing Nutrition to Delay Aging: A Plant-Based Telomere-Friendly Dietary Revolution.
Plasma Surgical Inc 2007
Open access · US-GOV